Quarterly report pursuant to Section 13 or 15(d)

Segments (Details)

v2.4.0.6
Segments (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Dec. 31, 2011
Information regarding our geographic activities          
Operating (loss) income from continuing operations $ (9,285) $ (4,775) $ (18,132) $ (8,911)  
Depreciation and amortization 2,366 936 4,782 1,818  
Total Product sales 9,917 8,428 18,556 15,378  
Total assets 230,471   230,471   229,489
Pharmaceutical [member]
         
Information regarding our geographic activities          
Operating (loss) income from continuing operations (5,426) (2,317) (11,457) (3,340)  
Depreciation and amortization 2,410 895 4,694 1,719  
Total assets 165,667   165,667   154,437
Corporate [Member]
         
Information regarding our geographic activities          
Operating (loss) income from continuing operations (3,859) (2,458) (6,675) (5,571)  
Depreciation and amortization 44 41 88 84  
Total assets 64,330   64,330   75,048
Discontinued Operations [Member]
         
Information regarding our geographic activities          
Total assets           4
United States [Member]
         
Information regarding our geographic activities          
Total Product sales              
Chile [Member]
         
Information regarding our geographic activities          
Total Product sales 7,187 12,189 12,888 12,189  
Mexico [Member]
         
Information regarding our geographic activities          
Total Product sales 1,212 3,164 2,523 3,164  
ISRAEL [Member]
         
Information regarding our geographic activities          
Total Product sales $ 1,518    $ 3,145